Assessment of the skin parameters moisture, melanin content, pH and production of sebum in patients treated with oral isotretinoine - Preliminary report;Ocena parametrów skóry - nawilżenia, zawartości melaniny, pH oraz sekrecji łoju - u pacjentów leczonych doustna̧ izotretynoina̧ - Doniesienie wstȩpne

Postepy Dermatologii i Alergologii

Volumn 27, Issue 2, 2010, Pages 83-89

  Bergler Czop, Beata ^a   Brzezińska Wcisło, Ligia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Acne; Isotretinoin; Side effects

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOTRETINOIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELANIN; TRIACYLGLYCEROL;

ACNE VULGARIS; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG SAFETY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MOISTURE; PH; SEBUM; SEBUM SECRETION; SIDE EFFECT; SKIN; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77952520523     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Braun-Falco O, Plewig G, Wolff HH, et al. Acne. In: Dermatology. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WH (eds). Springer-Verlag, Berlin-Heidelberg-New York 2000; 1051-1080
2. Thiboutot D. Pathogenesis and treatment of acne. J Eur Acad Dermatol Venerol 2001; 15: 91.
3. Wolska H. Rola terapii skojarzonej w tra̧dziku. Derm Klin Zabieg 2001; 3: 129.
4. Ramos-e-Silva M, Carneiro SC. Acne vulgaris: review and guidelines. Dermatol Nurs 2009; 21: 63-68
5. Vega B, Jomard A, Michel S. Regulation of human monocyte Toll-like receptor 2 (TLR2) expression by adapalene. J Eur Acad Dermatol Venerol 2002; 16: 123.
6. Miller LS. Toll-like receptors in skin. Adv Dermatol 2008; 24: 71-87.
7. Kim J, Ochoa MT, Krutzik SR, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 2002; 169: 1535-1541
8. Bergler-Czop B. Porównanie wczesnych i odległych wyników leczenia różnych postaci tra̧dziku u chorych leczonych w Klinice Dermatologii Śla̧skiej Akademii Medycznej w latach 1991-2000. Rozprawa doktorska. Śla̧ska Akademia Medyczna 2003.
9. Ghali F, Kang S, Leyden J, et al. Changing the face of acne therapy. Cutis 2009; 83 (2 suppl): 4-15.
10. Laubscher T, Regier L, Jin M, Jensen B. Taking the stress out of acne acne management. Can Fam Physician 2009; 55: 266-269
11. Nelson AM, Zhao W, Gilliland KL, et al. Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cell. J Clin Invest 2008; 118: 1468-1478 (Pubitemid 351500440)
12. Ghali F, Kang S, Leyden J, et al. Changing the face of acne therapy. Cutis 2009; 83 (2 Suppl): 4-15.
13. Bergler-Czop B, Brzezińska-Wcisło. Objawy niepoża̧dane u chorych na tra̧dzik leczonych izotretinoina̧. Pol Merk Lek 2005; 108: 680-685
14. Dreno B, Castell A, Tsankov N, et al. Interest of the association retinadehyde/glycolic acid in adult acne. J Eur Acad Dermatol Venereol 2009; 23: 529-532
15. Worobec SM, Wong FG, Tolman EL. Percutaneous absorption of 3H-tretinoin in normal volunteers. J Invest Dermatol 1991; 257: 574.
16. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol 2008; 9: 369-381
17. Beach RA, McQueen M, Wismer J. Novel management of isotretinoin-induced hypertriglyceridemia in an adolescent with severe acne. Clin Pediatr (Phila) 2009; 48: 551-554
18. Cumurcu T, Sezer E, Kilic R, Bulut Y. Comparison of dose-related ocular side effects during systemic isotretinoin administration. Eur J Ophthalmol 2009; 19: 196-200.
19. Isotretinoin and intestinal damage. Prescrire Int 2008; 17: 154-156
20. Shale M, Kaplan GG, Panaccione R, et al. Isotretinoin and intestinal inflammation: what gastroenterologists need to know. Gut 2009; 58: 737-741
21. Hadgraft J, Lane ME. Transepidermal water loss and skin site: a hypothesis. Int J Pharm 2009; 373: 1-3.
22. Bergler-Czop B, Brzezińska-Wcisło L. Wyniki leczenia tra̧dziku skupionego preparatem izotretinoiny - obserwacja w cia̧gu 10 lat w materiale Kliniki Dermatologii Śla̧skiej Akademii Medycznej. Dermatol Klin 2005; 2: 73-77 (Pubitemid 40780404)
23. Poradnik przepisywania i wydawania leku Aknenormin. Broszura informacyjna dla lekarzy. Boots Healthcare Sp. z o.o. 2007.
24. Yosipovitch G, Tang M, Dawn AG, et al. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Dermatol Venerol 2007; 87: 135-139 (Pubitemid 46513198)
25. Sun BK, Lee HK, Cho JC, et al. Clinical improvement of Skin Aging by Retinol Containing Products: With Non-Invasive Methods. IFSCC Conference Mexico 25-27 September 1997.
26. Schmidt-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol 2006; 6: 296-302. (Pubitemid 44808083)
27. Schürer NY, Bock M. Lowering lesional surface pH in acne: a new treatment modality for Herpfix. J Dermatolog Treat 2009; 20: 27-31.